Rare Neurology Launch Lead – ALS Access & Partnerships

Otsuka Pharmaceutical Companies (U.S.); United States; On-site; USD 158,000 - 252,000; Full time

Benefits offered by this job

401(k) match

Comprehensive benefits

Job summary

Otsuka Pharmaceutical Companies (U.S.) is seeking a Strategic Account Liaison to support the ALS program and rare neurology initiatives. The role focuses on communicating complex clinical data, treatment pathways, and patient access programs to ALS Centers of Excellence, healthcare providers, and key stakeholders.

The SAL will drive regional strategy, navigate hospital purchasing, reimbursement, and patient access while partnering with Market Access and Patient Support to remove barriers to

Qualifications

• Valid U.S. driver’s license and driving record in compliance with company standards.
• Bachelor’s Degree
• 10+ years in biotech/pharma commercial strategy
• Must reside in region

Responsibilities

• Educate on disease state awareness, screening and diagnostic pathways.
• Identify, develop, and maintain relationships with HCPs and KOLs.
• Create positive prescribing experiences through access and patient support programs.
• Engage with ALS Centers of Excellence to pull through Otsuka objectives.
• Collaborate with cross-functional teams to support patient care.
• Attend conferences and scientific meetings to educate on rare neurology diseases.

Skills

Clinical acumen

HCP engagement

KOL engagement

Strategic account plans

ALS Center navigation

Reimbursement knowledge

Cross-functional collaboration

Education delivery

Education

Bachelor’s Degree

Advanced clinical degrees prioritized

Job description

Otsuka Pharmaceutical Companies (U.S.) is seeking a Strategic Account Liaison to support the ALS program and rare neurology initiatives. The role focuses on communicating complex clinical data, treatment pathways, and patient access programs to ALS Centers of Excellence, healthcare providers, and key stakeholders.

The SAL will drive regional strategy, navigate hospital purchasing, reimbursement, and patient access while partnering with Market Access and Patient Support to remove barriers to